DIAGNOS Announces Closing of Private Placement
BROSSARD, Quebec, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a...
Syndax Pharmaceuticals Reports Inducement Grants Under
NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that...
OPTX) Launches Pioneering New York
ROCHESTER, NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a leading...
Interview Dives into How Trump Could Reverse America’s
Washington, D.C., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Jim Rickards warns that the United States has fallen shockingly behind in global mining....
Yorkville Acquisition Corp. Announces Ticker Symbol Change
WEST PALM BEACH, Fla., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Yorkville Acquisition Corp. (Nasdaq: YORK) (“Yorkville” or the “Company”), a special purpose...
BiomX CEO to Present at H.C. Wainwright 27th Annual Global
NESS ZIONA, Israel, Sept. 04, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE), a clinical-stage company advancing natural and engineered phage...
Global-e Announces Board Authorization of $200 Million
PETAH-TIKVA, Israel, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE) the platform powering global direct-to-consumer e-commerce, announced that its...
Actelis Networks Announces Launch of GigaLine 9000 Solution
Actelis’ GL9000 hybrid-fiber networking solution enables gigabit connectivity for buildings having hundreds of units, addressing opportunities in the multi-billion-dollar in-building connectivity market New...
Silexion Therapeutics Announces Selection of Contract
Strategic CRO to Support Path to Phase 2/3 Trials Following Recently Demonstrated Groundbreaking 97% Inhibition Rates for SIL204 Phase 2/3 Clinical Trials Expected...
Nasdaq Proposes Changes to its Listing Standards
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Today, Nasdaq proposed a new set of enhancements to its initial and continued listing...
Mesoblast Enters Into Option To Issue US$50 Million
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today...
Kodiak Copper Announces $7 Million Private Placement
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. ...
